EBN MEDICAL: what changed
EBN MEDICAL
Largest movements
- Receivables after one year -€180,000
no longer reported in 2025 (was €180,000)
- Current investments -€43,010
down €43,010 (-55.1%), from €78,010 to €35,000
- Receivables within one year -€37,150
down €37,150 (-89.9%), from €41,329 to €4,179
of which Other amounts receivable: -€32,992
- Cash -€32,538
down €32,538 (-35.2%), from €92,499 to €59,961
mainly Contributions, distributions and other (-€603,807) and Tax, wage and social debts (-€14,157)
- Profit (loss) carried forward -€442,775
no longer reported in 2025 (was €442,775)
- Other debts +€161,032
new in 2025: €161,032
- Tax, wage and social debts -€14,157
no longer reported in 2025 (was €14,157)
- Gross operating margin -€21,127
down €21,127 (-9.4%), from €224,895 to €203,767
- Financial income +€15,785
new in 2025: €15,785
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €460,633 | €164,164 | -€296,468 | -64.4% |
| Fixed assets | 21/28 | €19,362 | €15,052 | -€4,310 | -22.3% |
| Tangible fixed assets | 22/27 | €19,362 | €15,052 | -€4,310 | -22.3% |
| Plant, machinery and equipment | 23 | €15,925 | €13,167 | -€2,758 | -17.3% |
| Furniture and vehicles | 24 | €3,437 | €1,885 | -€1,552 | -45.2% |
| Current assets | 29/58 | €441,271 | €149,112 | -€292,159 | -66.2% |
| Amounts receivable after more than one year | 29 | €180,000 | - | -€180,000 | |
| Other amounts receivable | 291 | €180,000 | - | -€180,000 | |
| Amounts receivable within one year | 40/41 | €41,329 | €4,179 | -€37,150 | -89.9% |
| Trade receivables | 40 | €4,158 | - | -€4,158 | |
| Other amounts receivable | 41 | €37,171 | €4,179 | -€32,992 | -88.8% |
| Current investments | 50/53 | €78,010 | €35,000 | -€43,010 | -55.1% |
| Cash at bank and in hand | 54/58 | €92,499 | €59,961 | -€32,538 | -35.2% |
| Deferred charges and accrued income | 490/1 | €49,433 | €49,972 | +€539 | +1.1% |
| Total equity and liabilities | 10/49 | €460,633 | €164,164 | -€296,468 | -64.4% |
| Equity | 10/15 | €445,775 | €3,000 | -€442,775 | -99.3% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €442,775 | - | -€442,775 | |
| Amounts payable | 17/49 | €14,858 | €161,164 | +€146,307 | +985% |
| Amounts payable within one year | 42/48 | €14,858 | €161,164 | +€146,307 | +985% |
| Trade debts | 44 | €700 | €133 | -€568 | -81.1% |
| Suppliers | 440/4 | €700 | €133 | -€568 | -81.1% |
| Taxes, remuneration and social security | 45 | €14,157 | - | -€14,157 | |
| Taxes | 450/3 | €14,157 | - | -€14,157 | |
| Other amounts payable | 47/48 | - | €161,032 | +€161,032 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,361 | €5,279 | -€82 | -1.5% |
| Other operating charges | 640/8 | €2,488 | €2,230 | -€258 | -10.4% |
| Gross operating margin | 9900 | €224,895 | €203,767 | -€21,127 | -9.4% |
| Operating profit (loss) | 9901 | €217,046 | €196,259 | -€20,787 | -9.6% |
| Financial income | 75/76B | - | €15,785 | +€15,785 | |
| Recurring financial income | 75 | - | €15,785 | +€15,785 | |
| Financial charges | 65/66B | €1,245 | €978 | -€267 | -21.5% |
| Recurring financial charges | 65 | €1,245 | €978 | -€267 | -21.5% |
| Profit (loss) for the period before taxes | 9903 | €215,800 | €211,065 | -€4,735 | -2.2% |
| Income taxes | 67/77 | €51,157 | €50,034 | -€1,123 | -2.2% |
| Profit (loss) for the period | 9904 | €164,643 | €161,032 | -€3,612 | -2.2% |
| Profit (loss) for the period to be appropriated | 9905 | €164,643 | €161,032 | -€3,612 | -2.2% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.